Sakari Lassila
Chairman of the Board, Co-founder; M.Sc. (Econ. and BA)
Sakari has over 30 years of experience in international commercial and investment banking, corporate finance and investment company management, where he has held senior positions at Union Bank of Finland (now part of Nordea), Citibank, Alfred Berg and Carnegie.
Sakari is now active as a Board member in private and listed companies and a non-profit foundation.
Harry Holthöfer
Non-Executive Director, MD, PhD, Professor
Harry brings a wealth of international experience in translational research in diabetes, cardiovascular and kidney diseases.
He served as Professor of Bioanalytical Sciences and Director and Chair of the Centre for BioAnalytical Sciences at Dublin City University from 2006-2016 and is currently Research Director at University of Helsinki, Finland, Adjunct Professor at University of Shenzhen, China and Visiting Professor at University of Hamburg, Germany. Harry is also co-founder and CEO of three start-up biotech companies.
Kai Lindevall
Non-Executive Director, Co-founder; MD, PhD
Kai is former President and CEO of Encorium Group. He brings over twenty years of senior management and entrepreneurship experience in the life sciences sector gained at pharmaceutical, biotech and CRO companies. He was one of the founders of Remedium (a predecessor to Encorium) and Ipsat Therapies, and has served as Medical Advisor to Farmos, Medical Director to Rhône-Poulenc Rorer and as Associate Director of Research at Wihuri Research Institute in Helsinki, where he led his own research group involved in thrombosis research. Kai is the Chairman of the newly established company Siltana Ltd, developing new mobile solutions to improve drug safety and real world data access.
Steven Myint
Non-Executive Director, MD, PhD, Professor
Steve is an advisor to the chairman of Singapore’s Agency for Science and Technology, amongst other governmental organizations. Previous roles include Executive Chairman of Green Signal Bio, one of India’s largest independent vaccine manufacturers, Global Medical Director of GlaxoSmithKline and Senior Vice-President for R&D/Chief Medical Officer at BTG International. He is actively involved in innovative biotech companies and co-founded Finland’s largest accelerator fund.
He is a Fellow or Member of several UK societies, including the Institute of Knowledge Transfer, the Royal College of Physicians and the Royal Society of Medicine.
Jo Pisani
Non-Executive Director
Following 30 years in industry and consulting, Jo is now focused on supporting charities, universities and business start-ups. She is chair of London’s MedCity and Birmingham’s Precision Health Technology Accelerator. She serves on the boards of the UK Dementia Research Institute, LifeArc, The RSA Group and Beacon.
Prior to this, Jo led PwC’s UK Pharmaceutical and Life Sciences practice, and spent 20 years assisting clients with strategy, transformational change and deals. She started her career at BP and then GSK, with roles in strategy, commercial and operations functions.
She is a passionate supporter of critical public health issues, such as tackling dementia and addressing anti-microbial resistance. She is a fellow of the UK’s Institute of Engineering and Technology and is a chartered engineer.
